OTCMKTS:NMUS Nemus Bioscience (NMUS) Stock Price, News & Analysis → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NMUS Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.65▼$17.7552-Week Range N/AVolume1.00 million shsAverage Volume377,395 shsMarket Capitalization$87.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Nemus Bioscience alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Nemus Bioscience Stock (OTCMKTS:NMUS)Nemus Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus. Its products under research comprise NB2111 for use in treating chemotherapy induced peripheral neuropathy; and NB2222 for the treatment of uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy. Nemus Bioscience, Inc. has a license agreement with the University of Mississippi to research, develop, and commercialize products for the treatment of infectious diseases. The company was founded in 2012 and is headquartered in Costa Mesa, California.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. NMUS Stock News HeadlinesApril 23, 2024 | americanbankingnews.comNemus Bioscience (OTCMKTS:NMUS) Stock Price Crosses Below 50-Day Moving Average of $10.66April 19, 2024 | finance.yahoo.comYield10 Bioscience, Inc. (YTEN)April 25, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.March 16, 2024 | morningstar.comAssembly Biosciences Inc ASMBSeptember 5, 2023 | money.usnews.comSagimet Biosciences Inc - Ordinary Shares - Class AApril 27, 2023 | finance.yahoo.comSatellos Bioscience Announces Closing of Previously Announced Non-Brokered Offering of $2.385 Million of Unsecured Non-Convertible DebenturesApril 6, 2023 | finanznachrichten.deCrown Bioscience Announces Transaction Closing of Indivumed's Service Business and Supporting BiobankFebruary 24, 2023 | finance.yahoo.comPsycheceutical Bioscience Provisional Patent Application for Novel Ketamine Topical for the Treatment of PTSDApril 25, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.January 27, 2023 | finance.yahoo.comSN BioScience and Boryung Announce the Licensing Agreement on Generic Version of AbraxaneJanuary 27, 2023 | yahoo.comCrown Bioscience to Acquire Indivumed’s Service Business and Supporting BiobankJanuary 27, 2023 | finance.yahoo.comRenaissance BioScience Corp. and Timeless Capital Corp. Enter into Letter of IntentOctober 26, 2022 | finance.yahoo.comBioScience Managers Announces the Appointment of Dr. David Atkins as Managing Partner to Continue its Growth in Digital HealthSeptember 23, 2022 | finance.yahoo.comNeurocrine Biosciences, Inc. (NBIX)See More Headlines Receive NMUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nemus Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2018Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry N/A Sub-IndustryCannabis Current SymbolOTCMKTS:NMUS CUSIPN/A CIKN/A Webwww.nemusbioscience.com Phone949-396-0330FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-19,190,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-924.42% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.12) per share Price / BookN/AMiscellaneous Outstanding Shares133,908,000Free FloatN/AMarket Cap$87.04 million OptionableNot Optionable Beta-0.04 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Brian S. Murphy (Age 61)CEO, Chief Medical Officer & Director Dr. Avtar S. Dhillon (Age 57)Exec. Chairman Mr. Douglas A. Cesario (Age 44)Chief Financial Officer Ms. Wendy CunningVP of Bus. OperationsKey CompetitorsAtara BiotherapeuticsNASDAQ:ATRASELLAS Life Sciences GroupNASDAQ:SLSAbeona TherapeuticsNASDAQ:ABEOReviva PharmaceuticalsNASDAQ:RVPHIMACNASDAQ:IMACView All Competitors NMUS Stock Analysis - Frequently Asked Questions How were Nemus Bioscience's earnings last quarter? Nemus Bioscience Inc (OTCMKTS:NMUS) posted its earnings results on Tuesday, May, 15th. The biopharmaceutical company reported ($0.09) earnings per share for the quarter. What other stocks do shareholders of Nemus Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other Nemus Bioscience investors own include Emerald Health Therapeutics (EMHTF), KushCo (KSHB), MedMen Enterprises (MMNFF), Aurora Cannabis (ACBFF), CannaRoyalty (ORHOF), Unrivaled Brands (TRTC), BOTS (MCIG) and Cronos Group (CRON). How do I buy shares of Nemus Bioscience? Shares of NMUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NMUS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemus Bioscience Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
